Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to -$77.3 million.

  • Sotera Health's Cash from Financing Activities fell 2814.05% to -$77.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.9 million, marking a year-over-year decrease of 106.88%. This contributed to the annual value of -$50.6 million for FY2024, which is 119.01% down from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Cash from Financing Activities is -$77.3 million, which was down 1,015.52% from -$6.9 million recorded in Q2 2025.
  • Sotera Health's 5-year Cash from Financing Activities high stood at $273.9 million for Q1 2023, and its period low was -$103.4 million during Q3 2021.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$6.5 million (2024), whereas its average is $11.2 million.
  • As far as peak fluctuations go, Sotera Health's Cash from Financing Activities skyrocketed by 61,105.79% in 2023, and later slumped by 4,043.80% in 2024.
  • Quarterly analysis of 5 years shows Sotera Health's Cash from Financing Activities stood at -$1.8 million in 2021, then soared by 11,280.92% to $199.2 million in 2022, then tumbled by 101.90% to -$3.8 million in 2023, then plummeted by 72.63% to -$6.5 million in 2024, then tumbled by 2,814.05% to -$77.3 million in 2025.
  • Its Cash from Financing Activities stands at -$77.3 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$8.1 million for Q1 2025.